Ticker

No recent analyst price targets found for PCF.

Latest News for PCF

PCF: Deep Discount With Discounted Portfolio Exposure

The High Income Securities Fund offers deep diversification via a sleeve of fund-of-funds exposure, currently trading at a -11.50% discount to NAV. PCF's expense ratio is fairly high, which is compounded by underlying CEF and BDC fees, but the fund's discount-on-discount structure creates tactical appeal. The managed 10% distribution policy has led to payout reductions over time, but with the current yield at…

Seeking Alpha • Feb 12, 2026
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals Validated system provides reliable, consistent carbon footprint data for clients INCHEON, South Korea, Feb. 6, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing…

PRNewsWire • Feb 6, 2026
High Income Securities Fund (NYSE:PCF) Short Interest Update

High Income Securities Fund (NYSE: PCF - Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 22,741 shares, a decline of 43.4% from the November 30th total of 40,199 shares. Based on an average trading volume of 88,051

Defense World • Dec 27, 2025

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PCF.

No House trades found for PCF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top